Delivery Order SPE2DB22D1202-SPE2DB24FUMH6
Award Date 1/9/24
Potential Completion Date 1/10/24
Potential Value $22K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) has awarded a $3,041.73 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) awarded a $11,417.62 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product DESCOVY 200-25 MG TABLET UU 30S. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $6,894.30 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through March 18, 2024. This delivery order was placed under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $13,506.61 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562890254 DESCOVY 200-25 MG TABLET UU 30S pharmaceutical products. Performance will take place at Amerisourcebergen's Conshohocken, Pennsylvania headquarters, with all supplies delivered by November 24, 2023. No set-aside designation was applied to this award made under an existing DLA...
- This federal contract award is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $7,855.36 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has an ultimate completion date of October 16, 2024 and does not utilize a set-aside designation. AmerisourceBergen has been awarded numerous indefinite delivery...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of DESCOVY 200-25 MG TABLET 30S. The $1,860.70 delivery order has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563743834 - DESCOVY 200-25 MG TABLET UU 30S. The delivery order has a potential value of $3,634.31 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors mentioned. The contract does not have a set-aside designation....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,517.50 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a continuation of the company's role as a critical pharmaceutical...
- This federal contract award, valued at $12,113.50, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product DESCOVY 200-25 MG TABLET UU 30S. This is a firm fixed-price delivery order contract with a completion date of September 5, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor in the United...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order valued at $39,772.97 for the pharmaceutical product DESCOVY 200-25 MG TABLET. The prime contractor for this award is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUMH6Delivery Order
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $21,601.38 firm fixed price delivery order to supply DESCOVY 200-25 MG TABLET UU 30S pharmaceuticals. This order was placed against Amerisourcebergen's existing indefinite delivery contract with DLA to provide pharmaceutical products and medical supplies in support of military treatment programs and facilities. The contract has a period of performance through January 10, 2024 and does not have a set-aside designation. As a leading global pharmaceutical distribution company, Amerisourcebergen has extensive experience supporting the medical supply needs of U.S. government agencies, including the Department of Defense.
Generated 4/9/24, 6:16 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.6k | 1/9/24 |